// App-Quantinova.ai

MON-97 : Pasireotide Monotherapy in Cushin-s Disease: a single-centre experience with 5-year extension of Phase III trial

Researchers

Presenter

  • Isabelle Bourdeau

Principal Investigators

  • Sophie Vallette

  • Hugues Beauregard

  • Louis-Georges Ste-Marie

  • Andre Lacroix

Medical Centers

  • Centre Hospitalier de LUniversite de Montreal (CHUM), Montreal, QC, Canada

  • Hopital Notre-Dame, CHUM, Montreal, QC, Canada

  • Centre Hospitalier de LUniversite de Montreal (CHUM), Montreal, QC, Canada

  • CHUSJ, Montreal, Canada

  • CHUM-Hopital St-Luc, Montreal, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Cushing's syndrome

  • Gallbladder disease

  • Hyperglycemia

  • Arrhythmia

  • Diabetes

Biomarkers

  • Cortisol

Drug/Treatment

  • Pasireotide

  • Metformin Hydrochloride

Outcome

  • N/A

Study Design

  • open label

  • randomized

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved